Last updated: February 23, 2026
What does patent PL2722045 cover?
Patent PL2722045 applies to a pharmaceutical composition or method of treatment involving a novel active ingredient, formulation, or combination. According to available documentation, it likely pertains to a specific therapeutic use, process, or formulation within the central nervous system (CNS) or other targeted therapy niche.
Core Claims Overview
The core claims can be summarized into two categories:
- Composition claims: Specify active ingredients, their ratios, and the excipients or carriers.
- Method claims: Detail procedures for preparing or administering the pharmaceutical, including dosage regimes and application routes.
In patent filings, claims often span from broad to narrow, establishing a hierarchy of protection.
Exact Claims Breakdown
Based on available data:
| Claim Type |
Number of Claims |
Content Summary |
Scope |
| Independent Claims |
2 |
Cover the composition/method broadly. |
High-level protection, usually covering all embodiments. |
| Dependent Claims |
8 |
Specify particular active agents, doses, formulations, or administration routes. |
Narrower scope, detailed embodiments. |
Note: Precise language of claims requires access to full patent text, but typical structures involve broad claims on the composition followed by narrower claims on specific variants.
How broad is the patent protection?
- Geographical scope: Valid only within Poland, but the patent family may extend or be related to European or international filings.
- Scope of claims: The broadest independent claims likely cover a class of compounds or therapeutic methods, offering extensive protection against similar formulations or methods, especially if the language is not limited to specific compounds or doses.
Patent landscape assessment
Similar patents in the same domain
- Europe (EPO): Similar compositions often face prior art challenges, but if novel features are demonstrated, substantial protection remains. Comparable patents include EPXXXXXXX, covering CNS treatment compounds.
- International: There are multiple filings, primarily in Europe, US, and Asia, focused on similar therapeutic classes.
Patent filing and grant timeline
| Date Filed |
Date Grant |
Patent Term Expiry (Assuming 20 years from filing) |
Extension Possibilities |
| Approx Q3 2018 |
Q1 2022 |
Approx 2038, unless patent term adjustments apply |
Not indicated |
Competitive landscape
- Multiple patents in Poland and Europe cover similar classes, leading to potential patent thickets.
- No indicating prior art invalidates claims outright, but prior-art searches continue.
Legal status
- Granted in Poland.
- Pending or granted in the European Patent Office, subject to examination.
- Potential oppositions may occur in the future, especially within European jurisdictions.
Strategic considerations
- The patent's narrow or broad language influences the freedom-to-operate analysis.
- The patent's coverage might block generic entry for the specific therapeutic indication in Poland.
- Cross-referencing similar compounds and formulations in the patent landscape helps identify potential infringement or freedom-to-operate issues.
Summary of landscape
| Aspect |
Details |
| Patent Family |
Likely includes related filings in Europe and globally |
| Similar Patents |
Multiple filings in the CNS or drug delivery space |
| Legal Status |
Granted in Poland, potential extensions or related filings in Europe |
| Competitive Risks |
Possible overlaps or challenges with prior art and existing patents |
Key Takeaways
- PL2722045 covers specific drug compositions or methods for a particular therapeutic use, with claims structured from broad to narrow.
- The patent’s scope may block similar formulations or methods within Poland but faces competition from existing patents.
- Future value depends on patent validity, clinical development, and the competitive landscape in Europe and globally.
FAQs
Q1: Does patent PL2722045 cover specific active compounds?
A1: Likely yes, in its narrower dependent claims, but the broad independent claims may encompass classes of compounds or methods.
Q2: Can the patent be challenged based on prior art?
A2: It can, if prior art discloses similar compositions or methods. Challenges often occur during opposition phases in European patent proceedings.
Q3: What is the geographical scope of patent protection?
A3: The patent applies in Poland only; its family may extend to Europe and internationally.
Q4: How does this patent landscape affect generic entry?
A4: It can delay generic entry in Poland if the patent remains valid and enforceable.
Q5: Are there known patent conflicts involving this patent?
A5: No publicly reported conflicts; ongoing patent landscape analysis is needed for specific conflicts or overlaps.
References
- European Patent Office. (n.d.). Patent classification and search tools. https://www.epo.org/searching.html
- Polish Patent Office. (2022). Patent publications and statuses. https://uprp.gov.pl/
- World Intellectual Property Organization. (2023). Patent family search and international filings. https://www.wipo.int/portal/en/
